← Back to Search

Behavioral Intervention

Lifestyle Intervention for Obesity

N/A
Recruiting
Led By Moghboeba Mosavel
Research Sponsored by Virginia Commonwealth University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 or older
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 week and 24 weeks post-treatment
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a weight loss program specifically designed for African American adults living in economically disadvantaged areas. The goal is to see if using house chats as a model for the program is feasible and acceptable in

Who is the study for?
This trial is for African American adults who are at least 18 years old and live in Petersburg, VA. It's designed to help those living in economically disadvantaged areas reduce obesity and improve heart health through a community-based program.
What is being tested?
The study is testing a 12-week lifestyle intervention that includes 'house chats' as a method of delivering weight loss coaching. The goal is to see if this approach is practical and well-received in the community setting.
What are the potential side effects?
Since this trial involves lifestyle changes rather than medication, side effects may include muscle soreness from new exercise routines or adjustments to dietary habits but are generally expected to be minimal.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 week and 24 weeks post-treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 week and 24 weeks post-treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Intervention ward participants will manifest clinically significant change in adiposity
Participants in the intervention ward will manifest clinically significant Change in diet behavioral outcomes targeted in the intervention.
Participants in the intervention ward will manifest clinically significant change in physical activity outcomes targeted in the intervention.
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Participants will be randomized to intervention and will receive the 12-week program.
Group II: Delayed Intervention ControlActive Control1 Intervention
Participants will be randomized to delayed intervention control and will receive the same 12-week program.

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,464 Previous Clinical Trials
4,337,373 Total Patients Enrolled
472 Trials studying Obesity
590,934 Patients Enrolled for Obesity
Virginia Commonwealth UniversityLead Sponsor
719 Previous Clinical Trials
22,895,756 Total Patients Enrolled
31 Trials studying Obesity
5,706 Patients Enrolled for Obesity
Moghboeba MosavelPrincipal InvestigatorVirginia Commonwealth University
~5 spots leftby Mar 2025